A case of Miller Fisher syndrome during preoperative chemotherapy for breast cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 16914-16917

  Taki, Yumiko ^a   Ide, Yoshimi ^a   Tajima, Shogo ^b   Hosokawa, Yuko ^a   Matsunuma, Ryoichi ^a   Terada, Tatsuhiro ^a   Waki, Michihiko ^a   Ogura, Hiroyuki ^a   Shiiya, Norihiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

Breast cancer; Chemotherapy; Diplopia; Drug neurotoxicity; FEC treatment; Immunological response; Miller fisher syndrome; Myelosuppression; Ophthalmoplegia; Upper respiratory infection

Indexed keywords

AMBROXOL; CEFDITOREN PIVOXIL; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; IMMUNOGLOBULIN; PARACETAMOL; TIPEPIDINE;

ADULT; AREFLEXIA; ARTICLE; ATAXIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMMON COLD; DIPLOPIA; FEMALE; FEVER; GUILLAIN BARRE SYNDROME; HEARING IMPAIRMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOTHERAPY; INFECTION; LIMB WEAKNESS; MAMMOGRAPHY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROLOGIC EXAMINATION; NEUROTOXICITY; OPHTHALMOPLEGIA; PARESTHESIA; PARTIAL MASTECTOMY; SORE THROAT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84946600819     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler Ch, Verschuuren JJ, Vincent A, Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135-40.
2. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56: 1104-6.
3. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992; 31: 677-9.
4. Ministry of Health LaW. Manual for severe adverse effect according to diseases, Guillain-Barré syndrome. 2009.
5. Gonzalez Perez P, Serrano-Pozo A, Franco-Macias E, Montes-Latorre E, Gómez-Aranda F, Campos T. Vincristine-induced acute neurotoxicity versus Guillain-Barre syndrome: a diagnostic dilemma. Eur J Neurol 2007; 14: 826-8.
6. Kanaan Z, Kulairi Z, Titianu M, Saha S, Kumar S. Guillain-Barre Syndrome following Treatment with Sunitinib Malate. Case Rep Oncol Med 2014; 2014: 712040.
7. Vogel CL, Wojtukiewicz MZ, Carroll RR, Tjulandin SA, Barajas-Figueroa LJ, Wiens BL, Neumann TA, Schwartzberg LS. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 2005; 23: 1178-84.